Buphenine: Difference between revisions
Content deleted Content added
m →top: Protect -{ markup from preprocessor: phab:T146304, explained. using AWB Tag: nowiki added |
Rescuing 1 sources and tagging 0 as dead. #IABot (v1.5beta) |
||
| Line 42: | Line 42: | ||
}} |
}} |
||
'''Buphenine''' (or '''nylidrin''') is a [[Beta2-adrenergic agonist|β<sub>2</sub> adrenoreceptor agonist]]<ref name="pmid2857689">{{cite journal |vauthors=Mittag TW, Tormay A, Messenger M, Podos SM |title=Ocular hypotension in the rabbit. Receptor mechanisms of pirbuterol and nylidrin |journal=Invest. Ophthalmol. Vis. Sci. |volume=26 |issue=2 |pages=163–9 |date=February 1985 |pmid=2857689 |doi= |url=http://www.iovs.org/cgi/pmidlookup?view=long&pmid=2857689}}</ref> that acts as a [[vasodilator]]. |
'''Buphenine''' (or '''nylidrin''') is a [[Beta2-adrenergic agonist|β<sub>2</sub> adrenoreceptor agonist]]<ref name="pmid2857689">{{cite journal |vauthors=Mittag TW, Tormay A, Messenger M, Podos SM |title=Ocular hypotension in the rabbit. Receptor mechanisms of pirbuterol and nylidrin |journal=Invest. Ophthalmol. Vis. Sci. |volume=26 |issue=2 |pages=163–9 |date=February 1985 |pmid=2857689 |doi= |url=http://www.iovs.org/cgi/pmidlookup?view=long&pmid=2857689 |deadurl=yes |archiveurl=https://archive.is/20130415011509/http://www.iovs.org/cgi/pmidlookup?view=long&pmid=2857689 |archivedate=2013-04-15 |df= }}</ref> that acts as a [[vasodilator]]. |
||
==See also== |
==See also== |
||
*[[Isoxsuprine]] |
*[[Isoxsuprine]] |
||
Revision as of 14:44, 27 July 2017
 | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.006.531 |
| Chemical and physical data | |
| Formula | C19H25NO2 |
| Molar mass | 299.41 g/mol g·mol−1 |
| 3D model (JSmol) | |
| |
Buphenine (or nylidrin) is a β2 adrenoreceptor agonist[1] that acts as a vasodilator.
See also
References
- ^ Mittag TW, Tormay A, Messenger M, Podos SM (February 1985). "Ocular hypotension in the rabbit. Receptor mechanisms of pirbuterol and nylidrin". Invest. Ophthalmol. Vis. Sci. 26 (2): 163–9. PMID 2857689. Archived from the original on 2013-04-15.
{{cite journal}}: Unknown parameter|deadurl=ignored (|url-status=suggested) (help)
 | This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
 | This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |